Send to

Choose Destination
Am J Pharmacogenomics. 2005;5(6):397-407.

Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis.

Author information

Division of Clinical Pharmacology, Department of Pharmacology and Toxicology, University of Alabama, Birmingham, Alabama 35294-0019, USA.


This is the final part of a four-part serial review on oncogenes and their potential use as targets for cancer therapy. Previous sections discussed various categories of oncogenes (growth factors, tyrosine kinases, intermediate signaling molecules, and transcription factors) and the advances made in various strategies being used to alter their actions. This part describes four oncogenes, MDM2, BCL2, XIAP, and Survivin, that are involved in regulation of the cell cycle and apoptosis.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center